Geoffrey Ling
Board Member
Celularity Inc (CELU)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Geoffrey Ling
Geoffrey Ling is recorded as Board Member at Celularity Inc (CELU). Gyre Therapeutics, Inc. reported in an 8-K filed December 27, 2022 that Geoffrey Ling resigned as Director, effective December 26, 2022.
“On December 26, 2022, immediately prior to the F351 Effective Time, Errol B. De Souza, Ph.D., Jeanne Jew, Geoffrey Ling, M.D./Ph.D., Sharon Tetlow and Eddie Williams voluntarily resigned from Catalyst's Board of Directors (the "Board").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Gyre Therapeutics, Inc. (GYRE)
Proxy statement
Start not stated–2021-04-27
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Celularity Inc
Other people whose current roles at this company are on record from its filings.
- Robert J. Hariri CEO, Board Member
- John Sprague CFO
- Joseph DosSantos CFO
- Bradley Glover COO, CTO
- Bradley Glover, Ph.D. COO, CTO
- Steven N. Gordon, Esq. COO, Board Member
- K. Harold Fletcher General Counsel
- Geoffrey Shiu Fei Ling Board Member
- Jay R. Bloom Board Member
- Naveen Jain Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.